- Home
- Publications
- Publication Search
- Publication Details
Title
Inhaled Liposomal Antimicrobial Delivery in Lung Infections
Authors
Keywords
-
Journal
DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-20
DOI
10.1007/s40265-020-01359-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
- (2019) Charles S Haworth et al. Lancet Respiratory Medicine
- Alternatives to antibiotics in an era of difficult-to-treat resistance: new insights
- (2019) Jordi Rello et al. Expert Review of Clinical Pharmacology
- Ciprofloxacin nanocrystals liposomal powders for controlled drug release via inhalation
- (2019) Isra Khatib et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Inhaled Antibiotics for Mycobacterial Lung Disease
- (2019) Banaschewski et al. Pharmaceutics
- The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis
- (2019) Irena F Laska et al. Lancet Respiratory Medicine
- Effective treatment of the Mycobacterium avium subsp hominissuis and Mycobacterium abscessus sp. infections in macrophages, biofilm and in mice using Liposomal ciprofloxacin
- (2018) James D. Blanchard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial resistance and treatment: an unmet clinical safety need
- (2018) Matteo Bassetti et al. Expert Opinion On Drug Safety
- ECFS best practice guidelines: the 2018 revision
- (2018) Carlo Castellani et al. Journal of Cystic Fibrosis
- Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis – experiences from recent clinical trials
- (2018) Sheyla Paredes Aller et al. Expert Review of Respiratory Medicine
- The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases
- (2018) Roberto Nisini et al. Frontiers in Immunology
- Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT): A Prospective, Open-Label, Randomized Study
- (2018) David E Griffith et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- European Respiratory Society guidelines for the management of adult bronchiectasis
- (2017) Eva Polverino et al. EUROPEAN RESPIRATORY JOURNAL
- The fate of inhaled antibiotics after deposition in cystic fibrosis: How to get drug to the bug?
- (2017) Aukje C. Bos et al. Journal of Cystic Fibrosis
- Nebulized Liposomal Amphotericin B for Treatment of Pulmonary Infection Caused by Hormographiella aspergillata: Case Report and Literature Review
- (2017) Cendrine Godet et al. MYCOPATHOLOGIA
- Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague
- (2017) Karleigh A. Hamblin et al. Frontiers in Microbiology
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
- (2016) Andre C. Kalil et al. CLINICAL INFECTIOUS DISEASES
- Inhaled Antibiotics for Gram-Negative Respiratory Infections
- (2016) Eric Wenzler et al. CLINICAL MICROBIOLOGY REVIEWS
- Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014
- (2016) Lindsey M. Weiner et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications
- (2016) Mindaugas Rudokas et al. MEDICAL PRINCIPLES AND PRACTICE
- Epidemiology of invasive respiratory disease caused by emerging non-Aspergillusmolds in lung transplant recipients
- (2016) M. Peghin et al. Transplant Infectious Disease
- Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient
- (2016) Matteo Bassetti et al. Annals of Intensive Care
- Development of Liposomal Ciprofloxacin to Treat Lung Infections
- (2016) David Cipolla et al. Pharmaceutics
- Management ofPseudomonas aeruginosainfection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin
- (2015) Zarmina Ehsan et al. Future Microbiology
- Cystic fibrosis microbiology: Advances in antimicrobial therapy
- (2015) Valerie Waters et al. Journal of Cystic Fibrosis
- 10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology ofAspergillusspp. infection in lung transplantation
- (2015) Maddalena Peghin et al. TRANSPLANT INTERNATIONAL
- Patient-Specific Modeling of Regional Antibiotic Concentration Levels in Airways of Patients with Cystic Fibrosis: Are We Dosing High Enough?
- (2015) Aukje C. Bos et al. PLoS One
- Pharmacokinetics, pulmonary disposition and tolerability of liposomal gentamicin and free gentamicin in foals
- (2014) A. J. Burton et al. EQUINE VETERINARY JOURNAL
- Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics
- (2014) Bernhard Lehofer et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Inhaled antibiotics: dry or wet?
- (2014) H. A. W. M. Tiddens et al. EUROPEAN RESPIRATORY JOURNAL
- Probing the size limit for nanomedicine penetration into Burkholderia multivorans and Pseudomonas aeruginosa biofilms
- (2014) Katrien Forier et al. JOURNAL OF CONTROLLED RELEASE
- Inhaled liposomal amikacin
- (2014) Valerie Waters et al. Expert Review of Respiratory Medicine
- Inhaled colistin following lung transplantation in colonised cystic fibrosis patients: Table 1–
- (2013) Hendrik Suhling et al. EUROPEAN RESPIRATORY JOURNAL
- Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model
- (2013) Jie He et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The effects of suspension particle size on the performance of air-jet, ultrasonic and vibrating-mesh nebulisers
- (2013) Mohammad Najlah et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Phase II studies of nebulised Arikace in CF patients withPseudomonas aeruginosainfection
- (2013) J P Clancy et al. THORAX
- Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
- (2013) David J Serisier et al. THORAX
- Liposome: classification, preparation, and applications
- (2013) Abolfazl Akbarzadeh et al. Nanoscale Research Letters
- Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non–Cystic Fibrosis Bronchiectasis
- (2012) James D. Chalmers et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetics of Sequential Doses of Capreomycin Powder for Inhalation in Guinea Pigs
- (2012) L. Garcia-Contreras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis
- (2010) G. Chimote et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
- Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation
- (2010) Víctor Monforte et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infection
- (2009) O. O. Okusanya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Review on the Clinical Use of Inhaled Amphotericin B
- (2009) Laura Kuiper et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- A Gamma Scintigraphy Study to Investigate Lung Deposition and Clearance of Inhaled Amikacin-Loaded Liposomes in Healthy Male Volunteers
- (2009) Jeffry Weers et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety
- (2009) Víctor Monforte et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Genotoxic effects of neutrophils and hypochlorous acid
- (2009) N. Gungor et al. MUTAGENESIS
- Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis
- (2009) Misagh Alipour et al. PLoS One
- Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo‐Controlled Trial
- (2008) Bart J. Rijnders et al. CLINICAL INFECTIOUS DISEASES
- Aerosolized Antibiotics for Non-Cystic Fibrosis Bronchiectasis
- (2008) Bruce K. Rubin Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Characterization of Nebulized Liposomal Amikacin (Arikace™) as a Function of Droplet Size
- (2008) Zhili Li et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections
- (2008) P. Meers et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficiency and Safety of Inhaled Amphotericin B Lipid Complex (Abelcet) in the Prophylaxis of Invasive Fungal Infections Following Lung Transplantation
- (2008) J.M. Borro et al. TRANSPLANTATION PROCEEDINGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More